Home › Kanser sa Ovary › Ohio › Dayton

Pag-aaral pangklinika para sa Kanser sa Ovary sa Dayton, OH

9 pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Dayton (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

Miami Valley Hospital, Dayton
Premier Blood and Cancer Center, Dayton
Miami Valley Hospital North, Dayton
at 5 pa

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Nagre-recruitPhase 2

Kettering Medical Center /ID# 274365, Kettering · 5 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT06890338

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Nagre-recruitPhase 3

Miami Valley Hospital South, Centerville · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Nagre-recruitPhase 3

Miami Valley Hospital South, Dayton

Edad 18 pataas · Kababaihan · Na-update Set 15, 2026 · NCT07214779

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

Nagre-recruitPhase 3

Miami Valley Hospital South, Centerville · 9 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Set 9, 2026 · NCT07225270

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Nagre-recruitPhase 3

Kettering Health, Kettering · 5 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Ago 26, 2026 · NCT05281471

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Nagre-recruit

Miami Valley Hospital, Dayton
Miami Valley Hospital North, Dayton
Miami Valley Hospital South, Centerville · 9 mi ang layo
at 2 pa

Edad 35 hanggang 50 · Kababaihan · Na-update Ago 7, 2026 · NCT04251052

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Nagre-recruitPhase 2

304, Centerville · 9 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Hul 16, 2026 · NCT06906341

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Nagre-recruitPhase 3

Miami Valley Hospital South, Centerville · 9 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Hul 2, 2026 · NCT06819007

Pag-aaral para sa Kanser sa Ovary sa ibang lungsod

Iba pang pag-aaral sa Dayton

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.